|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
86618 JD HEALTH-R
Nominal 
33.980 0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 40,887,884 | 15.862% | 35,290,047 | 28,343,961 | 27,110,336 | 20,225,212 |
| Cost of Sales | (30,201,891) | 14.409% | (26,398,129) | (21,644,018) | (20,907,336) | (15,810,653) |
| Gross Profit | 10,685,993 | 20.176% | 8,891,918 | 6,699,943 | 6,203,000 | 4,414,559 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 10,738 | -- | (55,480) | 10,409 | (64,662) | (11,025) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (33,809) | -13.636% | (39,147) | (40,806) | (32,197) | (48,566) | |
| Profit / (Loss) before Taxation | 4,250,776 | 48.438% | 2,863,666 | 2,439,342 | 1,831,226 | 377,346 | |
| Taxation | (815,368) | 199.416% | (272,319) | (404,964) | (269,234) | (154,388) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 1,396 | -72.617% | 5,098 | 2,804 | (634) | 594 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 3,436,804 | 32.366% | 2,596,445 | 2,037,182 | 1,561,358 | 223,552 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (627,265) | -22.020% | (804,395) | (985,491) | (932,068) | (215,770) |
| Depreciation & Amortisation | 183,909 | 52.816% | 120,347 | 103,218 | 107,930 | 50,984 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 108.000 | 31.707% | 82.000 | 65.000 | 50.000 | 7.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 19.139 | -- | 18.116 | 16.344 | 15.309 | 13.326 |
| Remarks: | Real time quote last updated: 14/08/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 3,436,804 |
| %Change | 32.366% |
| EPS / (LPS) | RMB 1.080 |
| NBV Per Share (¥) | RMB 19.139 |